HPV vaccine delivery strategy depends on country

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.659, 2012-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers

By Hosseinzadeh Sahar  

Drug Delivery, Vol. 20, Iss. 3-4, 2013-04 ,pp. : 190-198

Informa Healthcare

Access to resources Recommend Favorite

HPV vaccine safety data reviewed

By  

Reactions Weekly, Vol. 1, Iss. 1234, 2009-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

HPV vaccine worth a shot in Europe

By  

Inpharma, Vol. 1, Iss. 1614, 2007-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

HPV vaccine prevents precancerous lesions

By  

Inpharma, Vol. 1, Iss. 1591, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Quadrivalent HPV vaccine immunogenic, safe

By  

Inpharma, Vol. 1, Iss. 1489, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite